XBI:ARCA-SPDR Series Trust S&P Biotech (USD)

ETF | Health | NYSE Arca

Last Closing

USD 103.01

Change

+0.57 (+0.56)%

Market Cap

USD 3.15B

Volume

8.13M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Inception Date: 31/01/2006

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.35%

Management Expense Ratio: 0.35 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

-0.88 (-0.59%)

USD 40.46B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

-0.29 (-0.41%)

USD 2.91B
FXH First Trust Health Care AlphaD.. 0.63 %

+0.65 (+0.58%)

USD 1.19B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

+0.78 (+0.84%)

USD 0.22B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.15 (+0.57%)

USD 0.15B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

+0.37 (+0.87%)

USD 0.13B
XHS SPDR® S&P Health Care Service.. 0.35 %

+2.06 (+2.13%)

USD 0.08B
HTEC Robo Global® Healthcare Techn.. 0.00 %

+0.27 (+0.91%)

USD 0.06B
BBP Virtus LifeSci Biotech Product.. 0.79 %

-0.45 (-0.66%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

+0.29 (+0.93%)

USD 0.01B

ETFs Containing XBI

MATH Metalpha Technology Holdi.. 0.00 % 1.35 %

+0.01 (+0%)

USD 0.05B
INAV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -61.54% 24% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.54% 24% F 8% B-
Trailing 12 Months  
Capital Gain -48.44% 24% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.44% 24% F 9% A-
Trailing 5 Years  
Capital Gain -59.10% 19% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.10% 19% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain 0.38% 24% F 36% F
Dividend Return 0.46% 24% F 25% F
Total Return 0.08% 26% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 32.98% 19% F 31% F
Risk Adjusted Return 1.38% 24% F 23% F
Market Capitalization 3.15B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.